Isolation of human adipose-derived stem cells from biopsies and liposuction specimens.

Pennington Biomedical Research Center, Baton Rouge, LA, USA.
Methods in Molecular Biology (Impact Factor: 1.29). 01/2008; 449:69-79. DOI: 10.1007/978-1-60327-169-1_5
Source: PubMed

ABSTRACT Adipose tissue has proven to serve as an abundant, accessible, and rich source of adult stem cells with multipotent properties suitable for tissue engineering and regenerative medical applications. Here, we describe a detailed method for the isolation and expansion of adipose-derived stem cells (ASCs). We present a large scale procedure suitable for processing >100 mL volumes of lipoaspirate tissue specimens and a small scale procedure suitable for processing adipose tissue biopsy specimens of < 0.5 g. Although we have focused on the isolation of ASCs from human adipose tissue, the procedure can be applied to adipose tissues from other species with minimal modifications.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Adipose-derived stem/stromal cells (ASCs) possess great potential as an autologous cell source for cell-based regenerative therapies. We have previously shown that mimicking the natural dynamic muscle loading patterns enhances differentiation capacity of ASCs into aligned myotubes. In particular, the application of uniaxial cyclic strain significantly increased ASC myogenesis in monolayer cultures. In this study, we demonstrate that the temporal expression of key myogenic markers Pax3/7, Desmin, MyoD and myosin heavy chain closely mimics patterns described for muscle satellite cells. Using these lineage markers, we propose that the progression from undifferentiated ASCs to myotubes can be described as transitions through discrete stages. Based on our experimental data, we developed a compartmental kinetic stage-transition model to provide a quantitative description of the differentiation of ASCs to terminally differentiated myotubes. The model describing ASCs’ myogenic differentiation in response to biophysical cues could help to obtain a deeper understanding of factors governing the biological responses and provide clues for experimental methods to increase the efficiency of ASC myogenesis for the development of improved muscle regenerative therapies.
    Cellular and Molecular Bioengineering 12/2014; 7(4). · 1.23 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Spinal cord injury (SCI) is one of the most serious clinical diseases and its treatment has been a subject of interest to researchers. There are two important therapeutic strategies in the treatment of SCI: replacing lost tissue cells through cells implantation and scar elimination. Therefore, in this study we used human adipose-derived stem cells (hADSCs) implantation and injection of Chondroitinase ABC. Aim of present study was to answer to this question: which one is more efficient for Improvement of locomotor recovery after SCI in rat? Transplantation of hADSCs or injection of ChABC. The spinal cord of rats was injured by contusion using a weight-drop at the level of T8-9, the hADSCs and Chondroitinase ABC were infused in to the spinal cord tissue after injury. BBB test was performed and recorded for each animal weekly for 8 weeks. After the 8(th) weeks, Serial cross-sections were stained with cresyl violet and examined under a light microscope and area of cavity in the spinal cord was measured. At 8(th) weeks after injection, hADSCs and ChABC significantly promote locomotor function (P<0.01) and spinal cords of hADSCs and ChABC group had cavities much smaller than those of the control group (P<0.001). Results of the present study shows dealing with inappropriate neuro-inhibitory environment and glial scar by ChABC have equal role compare to cell therapy (with hADSCs) for improving motor function after SCI and this result in adoption of proper therapeutic strategies for SCI intervention is important.
    Iranian Journal of Basic Medical Sciences 09/2014; 17(9):685-93.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Associate Editor Cynthia A. Reinhart-King oversaw the review of this article. Abstract—Efforts to create physiologically relevant micro-environments for cell differentiation have led to the creation of three-dimensional (3D) support matrices with varying physical and chemical properties. In an effort to simplify the complexity of these matrices, while maintaining their unique permeable nature, we investigated the culture and differen-tiation of adipose-derived stem cells (ADSCs) on porous membranes. Membranes offer many of the benefits of a 3D matrix, but simplify cell seeding, imaging, analysis and post-differentiation recovery. After inducing the differentiation of ADSCs into endothelial cells (ECs), the cells cultured on porous substrates produce more branch points and greater tube length in angiogenesis assays compared to the cells cultured on non-porous controls. While we confirm that ADSCs can be induced with vascular endothelial growth factor to express endothelial adhesion molecule CD31 (PECAM-1), only when co-cultured across a membrane with human umbilical vein endothelial cells (HUVECs), do a subset of ADSCs show appropriate CD31 distribution along cell boundaries. Others have recently described that mesenchymal stem cells derive from perivascular cells includ-ing pericytes, which are known to wrap circumferentially around microvessels. We used ultrathin porous membranes to permit limited physical interactions between polarized HUVECs and ADSCs. In this arrangement, we found that the majority of ADSCs aligned perpendicular to the polar-ized HUVECs even though contact between the cell types was limited by pores less than 500 nm in diameter. Together, this ADSC pericyte behavior in combination with the ability to differentiate into ECs shows the potential versatility of ADSCs in the engineering of vascular networks.
    Cellular and Molecular Bioengineering 08/2014; 7(3):369. · 1.23 Impact Factor

Full-text (2 Sources)

Available from
May 30, 2014